| Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy S Loibl, BM Müller, G von Minckwitz, M Schwabe, M Roller, ... Breast cancer research and treatment 130, 477-487, 2011 | 237 | 2011 |
| Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery B Ataseven, A du Bois, A Reinthaller, A Traut, F Heitz, S Aust, S Prader, ... Gynecologic oncology 138 (3), 560-565, 2015 | 167 | 2015 |
| Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator P Vlaicu, P Mertins, T Mayr, P Widschwendter, B Ataseven, B Högel, ... BMC cancer 13, 1-13, 2013 | 105 | 2013 |
| Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques J Heil, S Kümmel, B Schaefgen, S Paepke, C Thomssen, G Rauch, ... British journal of cancer 113 (11), 1565-1570, 2015 | 104 | 2015 |
| Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy B Ataseven, B Lederer, JU Blohmer, C Denkert, B Gerber, J Heil, T Kühn, ... Annals of surgical oncology 22, 1118-1127, 2015 | 104 | 2015 |
| Subcutaneous administration of monoclonal antibodies in oncology C Jackisch, V Müller, C Maintz, S Hell, B Ataseven Geburtshilfe und Frauenheilkunde 74 (04), 343-349, 2014 | 95 | 2014 |
| Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV B Ataseven, C Grimm, P Harter, F Heitz, A Traut, S Prader, A du Bois Gynecologic oncology 140 (2), 215-220, 2016 | 86 | 2016 |
| FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited B Ataseven, LM Chiva, P Harter, A Gonzalez-Martin, A du Bois Gynecologic oncology 142 (3), 597-607, 2016 | 85 | 2016 |
| Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes S Darb-Esfahani, G von Minckwitz, C Denkert, B Ataseven, B Högel, ... BMC cancer 14, 1-10, 2014 | 84 | 2014 |
| Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy JL Lindner, S Loibl, C Denkert, B Ataseven, PA Fasching, BM Pfitzner, ... Annals of oncology 26 (1), 95-100, 2015 | 83 | 2015 |
| Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis … SD Costa, S Loibl, M Kaufmann, DM Zahm, J Hilfrich, J Huober, ... J Clin Oncol 28 (1), 83-91, 2010 | 83 | 2010 |
| The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery C Grimm, P Harter, PF Alesina, S Prader, S Schneider, B Ataseven, ... Gynecologic oncology 146 (3), 498-503, 2017 | 81 | 2017 |
| Skeletal muscle attenuation (sarcopenia) predicts reduced overall survival in patients with advanced epithelial ovarian cancer undergoing primary debulking surgery B Ataseven, TG Luengo, A du Bois, KU Waltering, A Traut, F Heitz, ... Annals of Surgical Oncology 25, 3372-3379, 2018 | 73 | 2018 |
| Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy–Results from the multi-center SENTINA trial L Schwentner, G Helms, V Nekljudova, B Ataseven, I Bauerfeind, N Ditsch, ... The Breast 31, 202-207, 2017 | 70 | 2017 |
| Prognostic value of the age-adjusted Charlson comorbidity index (ACCI) on short-and long-term outcome in patients with advanced primary epithelial ovarian cancer A Kahl, A du Bois, P Harter, S Prader, S Schneider, F Heitz, A Traut, ... Annals of surgical oncology 24, 3692-3699, 2017 | 65 | 2017 |
| PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement S Gärtner, A Gunesch, T Knyazeva, P Wolf, B Högel, W Eiermann, ... PloS one 9 (1), e84472, 2014 | 63 | 2014 |
| Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer AS Wenners, K Mehta, S Loibl, H Park, B Mueller, N Arnold, S Hamann, ... Public Library of Science 7 (10), e45826, 2012 | 63 | 2012 |
| Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery F Heitz, P Harter, PF Alesina, MK Walz, D Lorenz, H Groeben, S Heikaus, ... Gynecologic oncology 141 (2), 264-270, 2016 | 61 | 2016 |
| Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer B Ataseven, C Grimm, P Harter, S Prader, A Traut, F Heitz, A du Bois Gynecologic oncology 135 (3), 435-440, 2014 | 61 | 2014 |
| LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced … MR Mirza, L Bjørge, F Marmé, RDP Christensen, M Gil-Martin, A Auranen, ... Annals of Oncology 31, S1160, 2020 | 59 | 2020 |
